Comprehensive early cancer risk assessment

Comprehensive early cancer risk assessment can detect 270 cancer genes in one go, and performs professional analysis based on the gene mutation data related to common cancers in Asia and Chinese populations, making the test results more accurate and consistent with the constitution of Asians and Chinese people. The new OEC test technology can detect the entire gene, unlike traditional methods that only detect hot-spot mutation sites, thus more comprehensively covering more gene mutations related to cancer development; it can also detect fusion genes, which are common in cancer, providing patients with more in-depth and comprehensive information.

• The test can be completed with a blood draw.
• Key coverage of common cancers in men and women
• The new generation of gene sequencing technology has a detection accuracy of up to 99.9%.
• Hong Kong's first privately owned laboratory with NGS equipment